Group No. | PET scanner | Gender (F/M*) | Age (y#) | Cancer type | Patients included | Lesions included |
---|---|---|---|---|---|---|
1 | mCT | 10/13 | 60.04 ± 8.64 | Lung cancer | 15 | 67 |
Hepatic cancer | 2 | 16 | ||||
Gallbladder carcinoma | 1 | 18 | ||||
Esophageal cancer | 1 | 4 | ||||
Pancreatic cancer | 1 | 9 | ||||
Non-Hodgkin’s lymphoma | 1 | 9 | ||||
Melanoma | 1 | 2 | ||||
Rectal carcinoma | 1 | 3 | ||||
Diffuse large B cell lymphoma | 1 | 5 | ||||
1 | Gemini | 5/10 | 60.33 ± 9.09 | Lung cancer | 5 | 19 |
Non-Hodgkin’s lymphoma | 4 | 31 | ||||
Esophageal cancer | 2 | 8 | ||||
Colon cancer | 2 | 11 | ||||
Diffuse large B cell lymphoma | 1 | 6 | ||||
Breast cancer | 1 | 4 | ||||
2 | mCT & Gemini | 8/3 | 52.09 ± 14.79 | Non-Hodgkin’s lymphoma | 6 | 19 |
Hodgkin’s lymphoma | 2 | 2 | ||||
Diffuse large B cell lymphoma | 1 | 3 | ||||
Lung cancer | 1 | 1 | ||||
Esophageal carcinoma | 1 | 2 | ||||
3 | mCT | 7/7 | 59 ± 9.21 | Lung cancer | 11 | 19 |
Non-Hodgkin’s lymphoma | 1 | 9 | ||||
Rectal adenocarcinoma | 1 | 3 | ||||
Melanoma | 1 | 2 |